Articles From: Grupo Financiero Santander Mexico Announces That Its Parent Company, Banco Santander, S.A. Has Signed An Alliance With A Group Led By Warburg Pincus To Create A Leader In The Custody Business to GSV Capital Corp. to Present at Oppenheimer's Technology, Internet & Communications Conference on August 13, 2014


2014/6/19
-- A group led by Warburg Pincus that includes Temasek will acquire a 50% stake in Santander's custody business in Spain, Mexico and Brazil subject to legal and regulatory approvals.
Sign-up for Grupo Financiero Santander Mexico Announces That Its Parent Company, Banco Santander, S.A. Has Signed An Alliance With A Group Led By Warburg Pincus To Create A Leader In The Custody Business investment picks
2014/9/10
MEXICO CITY, Mexico , Sept.
Sign-up for Grupo Financiero Santander Mexico Regrets to Announce that its Parent Company, Banco Santander, S.A. Chairman Emilio Botin has Passed Away investment picks
2014/7/31
- Loan portfolio growth driven by YoY increases of 26.8% in SMEs, 8.3% in credit cards, 11.0% in consumer loans, 32.0% in mortgages and 22.6% in middle-market - Continued prudent risk management reflected in a NPL ratio of 3.3% (1.9% excluding homebuilders and Santander Vivienda portfolio) and in a cost of risk of 3.4% - Ongoing emphasis on operating efficiency resulted in an improved efficiency ratio of 42.9%, despite higher branch expansion expenses MEXICO CITY , July 31, 2014 /PRNewswire/ -- Grupo Financiero Santander Mexico, S.A.B. de C.V., (NYSE: BSMX; BMV: SANMEX), ("Santander Mexico"), one of the leading financial groups in the Mexican financial system, today announced financial results for the three-month period ending June 30, 2014 .
Sign-up for Grupo Financiero Santander Mexico Reports Second Quarter 2014 Loan Portfolio Up 20.6% YoY and Net Income of Ps.3,687 Million investment picks
2014/7/14
MEXICO CITY , July 14, 2014 /PRNewswire/ -- Grupo Financiero Santander Mexico, S.A.B. de C.V. (BMV: SANMEX; NYSE: BSMX) ("Santander Mexico"), one of the leading financial groups in Mexico , announced today that to align its reporting date with its parent company, Banco Santander S.A., it will release its fiscal second quarter 2014 financial results before market open on Thursday, July 31, 2014 , which is after the reporting deadline of July 28, 2014 established by the Mexican National Banking and Securities Commission ("CNBV"). A conference call will be held on July 31, 2014 at 10:00 am U.S. ET ( 9:00 am Mexico City Time). The conference call can be accessed by dialing 1-888-778-9064 (U.S./ Canada ) or 1-913-312-1466 (International) and entering pass code 9173916.
Sign-up for Grupo Financiero Santander Mexico Will Report 2Q14 Results Before Market Open on July 31, 2014 investment picks
2014/7/24
GUADALAJARA, Mexico , July 24, 2014 /PRNewswire/ -- Grupo Simec, S.A.B. de C.V. (NYSE: SIM) ("Simec") announced today its results of operations for the sixth-month period ended June 30, 2014 .
Sign-up for Grupo Simec Announces Results of Operations for the First Six Months of 2014 investment picks
2014/7/28
http://media.marketwire.com/attachments/201102/37860_grupotmmlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133689&ProfileId=051205&sourceType=1 MEXICO CITY, MEXICO --
Sign-up for Grupo TMM Will Report Second-Quarter 2014 Financial Results by August 22 investment picks
2014/6/23
~ Wins include a Gold, two Silver and a Bronze, 10 shortlist nominations AUSTIN, Texas , June 23, 2014 /PRNewswire/ -- Austin's GSD&M, the country's leader in purpose-based marketing and branding, picked up a coveted Gold and two Silver Cyber Lion Awards for The U.S. Air Force Collaboratory platform and a Bronze Cyber Lion for the RadioShack "Goodbye, '80s" Super Bowl campaign at the 2014 Cannes Lions Festival—the world's leading celebration of creativity in communications.
Sign-up for GSD&M Honored With Four Cyber Lions At Cannes Lions Festival investment picks
GSE Successfully Implements a Consensual "Pre-Arranged" Chapter 11 Reorganization That Materially Deleverages Its Balance Sheet and Positions GSE for Long-Term Growth and Profitability HOUSTON , July 28, 2014 /PRNewswire/ -- GSE Environmental, Inc. ("GSE") (OTCQB: GSEHQ), the leading global manufacturer and marketer of geosynthetic lining solutions, announced that it has received confirmation of its Plan of Reorganization from the Bankruptcy Court for the District of Delaware , which has been overseeing the Company's Chapter 11 proceedings following its voluntary filing on May 4 , 2014.
Sign-up for GSE Environmental Chapter 11 Plan of Reorganization Confirmed - GSE Plans to Emerge From Chapter 11 Shortly investment picks
- Second Quarter 2014 Revenue of $96.9 million, 21% year-over-year growth - Second Quarter 2014 Adjusted EBITDA from Continuing Operations of $14.5 million - Second Quarter 2014 Earnings Per Share from Continuing Operations of $0.10 - Second Quarter 2014 Non-GAAP Earnings Per Share from Continuing Operations of $0.19 - Second Quarter 2014 Net Debt of $89.7 million BEDFORD, Mass.
Sign-up for GSI Group Announces Financial Results for the Second Quarter 2014 investment picks
2014/8/27
DALLAS , Aug.
Sign-up for GSI Technology Stockholders Encouraged to Contact Securities Law Firm about Takeover investment picks
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1137071&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. Announces Final Results of Modified Dutch Auction Tender Offer investment picks
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1136148&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. Announces Preliminary Results of Modified Dutch Auction Tender Offer investment picks
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142560&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. Board Unanimously Rejects Unsolicited Acquisition Proposal From GigOptix, Inc. investment picks
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1138770&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. Receives Unsolicited Acquisition Proposal investment picks
http://media.marketwire.com/attachments/201301/55618_gsitechnologylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134778&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for GSI Technology, Inc. Reports First-Quarter Fiscal 2015 Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G018847-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/7/22/11G018847/55618_gsitechnologylogo-819041953321.jpg SUNNYVALE, CA--(Marketwired - July 22, 2014) - GSI Technology, Inc. (NASDAQ: GSIT) will release financial results for its first-quarter fiscal 2015 ended June 30, 2014 at the market close on Thursday, July 31, 2014.
Sign-up for GSI Technology, Inc. to Announce First-Quarter Fiscal 2015 Results on July 31, 2014 investment picks
Company Announcement Trial did not meet the primary endpoint of Progression Free Survival Data to be further analyzed in the coming months COPENHAGEN, Denmark, June 27, 2014 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE:GSK) and Genmab A/S (Copenhagen:GEN) announced today that the Phase III study of ofatumumab (Arzerra(tm)) versus physicians' choice in patients with bulky fludarabine-refractory chronic lymphocytic leukaemia (CLL) did not meet its primary endpoint of progression free survival (PFS). The median PFS, as assessed by the Independent Review Committee, was 5.36 months for ofatumumab and 3.61 months for physicians' choice (Hazard Ratio 0.79, p=0.267). The result reported today is headline data; the full analysis of safety and efficacy data is underway and will be completed in the coming months.
Sign-up for GSK and Genmab announce top-line results from a Phase III study of ofatumumab versus physicians' choice for bulky fludarabine-refractory CLL investment picks
Company Announcement Arzerra approved for use in EU as first-line treatment for CLL in combination with chlorambucil or bendamustine for patients ineligible for fludarabine-based therapy Approval based on Phase III data from study with ofatumumab + chlorambucil & Phase II data from study with ofatumumab and bendamustine COPENHAGEN, Denmark, July 3, 2014 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE:GSK) and Genmab A/S (Copenhagen:GEN) announced today that the European Commission (EC) has granted marketing authorization for a new indication for the use of Arzerra (tm) (ofatumumab), a human monoclonal antibody against CD20, in combination with chlorambucil or bendamustine for the treatment of patients with chronic lymphocytic leukemia (CLL) who have not received prior therapy and who are not eligible for fludarabine-based therapy.
Sign-up for GSK and Genmab Receive EU Authorization for Arzerra(tm) (ofatumumab) as First-Line Treatment for Chronic Lymphocytic Leukemia (CLL) in Combination with Chlorambucil or Bendamustine for Patients Ineligible for Fludarabine-based Therapy investment picks
http://media.marketwire.com/attachments/201406/75933_logo1.jpg http://media.marketwire.com/attachments/201404/74550_gsk.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1131553&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA --
Sign-up for GSK and Theravance Announce Initiation of Phase III Programme With Fixed Dose Triple Combination Treatment FF/UMEC/VI in Patients With COPD investment picks
GSK announces EU regulatory submission for malaria vaccine candidate RTS,S Canada NewsWire LONDON , July 24, 2014 /CNW/ - GSK announced today that it has submitted a regulatory application to the European Medicines Agency (EMA) for its malaria vaccine candidate, RTS,S. The submission will follow the Article 58 procedure, which allows the EMA to assess the quality, safety and efficacy of a candidate vaccine, or medicine, manufactured in a European Union (EU) member state, for a disease recognised by the World Health Organization (WHO) as of major public health interest, but intended exclusively for use outside the EU.
Sign-up for GSK announces EU regulatory submission for malaria vaccine candidate RTS,S investment picks
2014/9/8
LONDON--U.K. drugmaker GlaxoSmithKline PLC (GSK.LN) Monday publicized positive results from a late-stage study of a treatment for pulmonary arterial hypertension, a condition characterized by constriction of the blood vessels in the lungs.
Sign-up for GSK Announces Results of Late-Stage PAH Trial With Gilead investment picks
- New first-in-class treatment option for this previously treated SAA patient population LONDON , Aug.
Sign-up for GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST) investment picks
New site is filled with information, patient testimonials, easy-to-use tools and real-world tips for people affected by COPD RESEARCH TRIANGLE PARK, N.C. , Aug.
Sign-up for GSK's COPD.com Relaunch Promotes Understanding and Dialogue about COPD investment picks
2014/7/29
PHILADELPHIA , July 29, 2014 /PRNewswire/ -- GSK (LSE/NYSE: GSK) today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S. Cheryl MacDiarmid , Vice President of GSK's General Medicine business said, "With approximately 21 million adults diagnosed with diabetes in the US 1 , and up to 95 percent of those patients living with type 2 diabetes, we're excited that for the appropriate patients Tanzeum is now available as a treatment option for healthcare professionals." Tanzeum, a glucagon-like peptide-1 (GLP-1) receptor agonist, is a once weekly option for patients, in combination with some other glucose-lowering medicines.
Sign-up for GSK's Tanzeum™ is now available in pharmacies in the U.S. investment picks
WOODSIDE, Calif., June 20, 2014 (GLOBE NEWSWIRE) -- GSV Capital Corp., ("GSV"), (Nasdaq:GSVC) , today announced that William Tanona was appointed GSV's Chief Financial Officer, Treasurer and Secretary and Carl Rizzo was named Chief Compliance Officer, both appointments are effective June 18, 2014.
Sign-up for GSV Capital Corp. Announces Management Transitions investment picks
WOODSIDE, Calif., Aug.
Sign-up for GSV Capital Corp. Reports Second Quarter 2014 Results of Operations investment picks
WOODSIDE, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- GSV Capital Corp., ("GSV"), (Nasdaq:GSVC) , today announced that CEO and Founder Michael T.
Sign-up for GSV Capital Corp. to Present at Needham's Annual Interconnect Conference on August 5, 2014 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Grupo Financiero Santander Mexico Announces That Its Parent Company, Banco Santander, S.A. Has Signed An Alliance With A Group Led By Warburg Pincus To Create A Leader In The Custody Business to GSV Capital Corp. to Present at Oppenheimer's Technology, Internet & Communications Conference on August 13, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices